… Pivotal study of edaravone to treat ALS Here, we review clinical trials using edaravone to
treat Amyotrophic lateral sclerosis (ALS) [Citation1–Citation3]. One was an open-label small-…

… This study showed that edaravone treatment for 7 days could only produce a modest clinical
… Certainly with treatment durations of 6 – 14 days for the clinical efficacy studies assessed in …

… that the administration of edaravone just prior to … clinical outcomes in AMI patients have not
yet been clarified. The purpose of the present study was to clarify the efficacy of edaravone on …

… pharmacological properties of edaravone and the progress of clinical trials conducted to
evaluate the efficacy of this drug in the treatment of ALS. Expert commentary: Edaravone is the …

… This study aims to evaluate the efficacy of edaravone in terms of functional … the efficacy of
edaravone outside Japan. The aim of this study was to investigate the effects of edaravone in …

… of edaravone in the treatment of amyotrophic lateral sclerosis remain controversial. We
performed a meta-analysis to evaluate the efficacy and safety of edaravone in the treatment of …

… safety and efficacy of Edaravone Dexborneol compared with edaravone in treating patients
… Our result showed that, compared with edaravone alone, Edaravone Dexborneol was safe …

… In summary, evidence for the efficacy of edaravone in the treatment of patients with ALS
is limited to short-term beneficial effects on disease progression observed in the MCI186-19 …

… However, a recent study showed that intravenous edaravone may not provide any disease-…
clinical efficacy of edaravone and whether edaravone should be recommended for treating …

… Edaravone is an antioxidant and oxygen radical scavenger that can inhibit lipid peroxidation
… This is the first randomized controlled trial to assess the efficacy of edaravone for treating …